Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

PD Controller: Design01:26

PD Controller: Design

630
In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
630
Time-Domain Interpretation of PD Control01:07

Time-Domain Interpretation of PD Control

383
Proportional-Derivative (PD) control is a widely used control method in various engineering systems to enhance stability and performance. In a system with only proportional control, common issues include high maximum overshoot and oscillation, observed in both the error signal and its rate of change. This behavior can be divided into three distinct phases: initial overshoot, subsequent undershoot, and gradual stabilization.
Consider the example of control of motor torque. Initially, a positive...
383
Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

9.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.2K
Frequency-Domain Interpretation of PD Control01:24

Frequency-Domain Interpretation of PD Control

356
Proportional-Derivative (PD) controllers are widely used in fan control systems to improve stability and performance. A fan control system can be effectively represented using a Bode plot to illustrate the impact of a PD controller through its transfer function. The Bode plot visually conveys how PD control modifies the fan's response across various frequencies, providing a frequency domain interpretation of the controller's behavior.
The proportional control gain, combined with the...
356
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of antimicrobial treatment in sepsis.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022
Same author

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2022
Same author

The pharmacodynamic bases of the prescription of antimicrobials.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2019
Same author

Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2019
Same author

[Aflibercept. An approach to pharmacology].

Archivos de la Sociedad Espanola de Oftalmologia·2015
Same author

[Ranibizumab versus bevacizumab. Pharmacological considerations].

Archivos de la Sociedad Espanola de Oftalmologia·2013

Related Experiment Video

Updated: Jan 21, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.1K

Ceftobiprole: pharmacokinetics and PK/PD profile.

J R Azanza Perea1, B Sádaba Díaz de Rada

  • 1José Ramón Azanza Perea, Clinical Pharmacology Department. Clínica Universidad de Navarra (University of Navarra Clinic). Avenida Pio XII 36. Pamplona 31008, Spain. jrazanza@unav.es.

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|August 1, 2019
PubMed
Summary

Ceftobiprole, administered intravenously, distributes into extracellular fluid and tissues. Dose adjustments are necessary for renal impairment but not for other patient factors, ensuring effective antibiotic concentration.

More Related Videos

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.1K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.1K

Related Experiment Videos

Last Updated: Jan 21, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.1K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.1K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.1K

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Infectious Diseases

Background:

  • Ceftobiprole medocaril is an intravenous cephalosporin antibiotic.
  • It is administered as a prodrug, hydrolyzed to the active form in the bloodstream.
  • Understanding its pharmacokinetic profile is crucial for optimizing therapeutic use.

Purpose of the Study:

  • To characterize the pharmacokinetic (PK) properties of ceftobiprole.
  • To evaluate the impact of renal function on ceftobiprole dosage requirements.
  • To determine appropriate dosing regimens for various patient populations.

Main Methods:

  • Pharmacokinetic analysis of ceftobiprole distribution and elimination.
  • Evaluation of dosing regimens, including intravenous infusion parameters.
  • Assessment of dose adjustments in patients with renal impairment and those on renal replacement therapy.

Main Results:

  • Ceftobiprole distributes primarily into extracellular fluid and achieves therapeutic concentrations in tissues.
  • Elimination is exclusively renal, necessitating dose adjustments for moderate to severe renal impairment.
  • No dose adjustments are required for age or body weight; however, increased dosing may be needed for renal replacement therapy.
  • The half-life exceeds 3 hours, facilitating achievement of pharmacokinetic/pharmacodynamic (PK/PD) targets with a 2-hour infusion.

Conclusions:

  • Ceftobiprole exhibits predictable pharmacokinetics suitable for intravenous administration.
  • Renal function is the primary determinant for ceftobiprole dose adjustments.
  • The established dosing regimen and infusion time support effective therapeutic outcomes.